Sialic Acid-Modified NIR-II Fluorophore with Enhanced Brightness and Photoconversion Capability for Targeted Lymphoma Phototheranostics
Analytical Chemistry · 2025
DOI: 10.1021/acs.analchem.4c06424 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2025. Verfasst von Fang Nan und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Key Laboratory of Space Bioscience & Biotechnology, Northwestern Polytechnical University, Xi'an 710072, China. Hauptthemen laut MEDLINE: Lymphoma, Fluorescent Dyes, Photosensitizing Agents, N-Acetylneuraminic Acid. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National College Students Innovation and Entrepreneurship Training Program, National Natural Science Foundation of China, Natural Science Foundation of Shaanxi Province.
Abstract (Originalsprache)
Lymphoma is a malignant cancer characterized by a rapidly increasing incidence, complex etiology, and lack of obvious early symptoms. Efficient theranostics of lymphoma is of great significance in improving patient outcomes, empowering informed decision-making, and driving medical innovation. Herein, we developed a multifunctional nanoplatform for precise optical imaging and therapy of lymphoma based on a new photosensitizer (1-oxo-1H-benzoo[de]anthracene-2,3-dicarbonitrile-triphenylamine (OBADC-TPA)). OBADC-TPA is a donor-acceptor (D-A) molecule characterized by a novel small coplanar and strong electron-withdrawing acceptor skeleton, while the OBADC moiety facilitates strong intramolecular charge transfer. OBADC-TPA-based nanoparticles (NPs) were prepared through encapsulation with an amphiphilic polymer and subsequent modification with sialic acid (SA). Both in vitro and in vivo studies demonstrated that NPs-SA possessed good biocompatibility, effective tumor accumulation, high photoacoustic (PA) contrast, bright second near-infrared (NIR-II) fluorescence emission, and efficient photothermal/photodynamic conversion capabilities, which can serve as a multifunctional nanocomposite for targeted PA/NIR-II fluorescence imaging-guided synergistic type I/II photodynamic and photothermal therapy (PDT/PTT) of lymphoma. This work not only provides a new NIR-II fluorophore with a novel acceptor moiety but also offers a new, accurate, and effective approach for the targeted diagnosis and treatment of lymphoma, holding promising prospects for clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, Key Laboratory of Space Bioscience & Biotechnology, Northwestern Polytechnical University, Xi'an 710072, China.
- School of Materials Science and Engineering, Jiangsu Collaboration Innovation Center of Photovoltaic Science and Engineering, Jiangsu Engineering Laboratory of Light-Electricity-Heat Energy-Converting Materials and Appl…
- Guangxi Key Lab of Processing for Nonferrous Metals and Featured Materials and Key Lab of New Processing Technology for Nonferrous Metals and Materials, Ministry of Education; School of Resources, Environments and Mater…
Förderung
- National College Students Innovation and Entrepreneurship Training Program
- National Natural Science Foundation of China
- Natural Science Foundation of Shaanxi Province
Zitieren
APA
Nan, F., Zhou, Z., Bai, Q., Chen, K., Liu, Y., & Wu, S. (2025). Sialic Acid-Modified NIR-II Fluorophore with Enhanced Brightness and Photoconversion Capability for Targeted Lymphoma Phototheranostics. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.4c06424
Vancouver
Nan F, Zhou Z, Bai Q, Chen K, Liu Y, Wu S. Sialic Acid-Modified NIR-II Fluorophore with Enhanced Brightness and Photoconversion Capability for Targeted Lymphoma Phototheranostics. Analytical Chemistry. 2025. doi:10.1021/acs.analchem.4c06424
BibTeX
@article{Nan2025,
author = {Nan, Fang and Zhou, Zhongxin and Bai, Qian and Chen, Kai and Liu, Yu and Wu, Shuqi},
title = {Sialic Acid-Modified NIR-II Fluorophore with Enhanced Brightness and Photoconversion Capability for Targeted Lymphoma Phototheranostics},
journal = {Analytical Chemistry},
year = {2025},
doi = {10.1021/acs.analchem.4c06424}
}
EUVIMED